• 1
    Kaleab B, Ottenoff T, Converse P, Halapi E, Tadesse G, Rottenberg M & Kiessling R. Mycobacterial-induced cytotoxic T lymphocyte as well as non-specific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol 1990; 20:2651.
  • 2
    Lorgat F, Keraan MM, Lukey PT & Ress SR. Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculosis pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis 1992; 145:418.
  • 3
    Barnes PF, Modlin RL & Ellner JJ. T cell responses and cytokines. In: BloomBR, ed. Tuberculosis: Pathogenesis, Protection and Control. Washington: ASM Press, 1994::417.
  • 4
    De Libero G, Flesch I & Kaufmann SHE. Mycobacteria reactive Lyt2+ T cell lines. Eur J Immunol 1988; 18:59.
  • 5
    Serbina NV, Liu CC, Scanga CA & Flynn JL. CD8+ CTL from lungs of M. tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000; 165:353.
  • 6
    Flynn JL, Goldstein MM, Triebold KJ, Koller B & Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium infection. Proc Natl Acad Sci USA 1992; 89:12013.
  • 7
    Behar S, Dascher CC, Grusby MJ, Wang CR & Brenner MB. Susceptibility of mice deficient in CD1d or TAP1 to infection with M. tuberculosis. J Exp Med 1999; 189:1973.
  • 8
    Turner J & Dockrell HM. Stimulation of human peripheral blood mononuclear cells with live M. bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 1996; 87:339.
  • 9
    Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK & Rich EA. Human alveolar T lymphocyte responses to M. tuberculosis antigens. J Immunol 1997; 159:290.
  • 10
    Lalvani A, Brookes R & Wilkinson RJ et al. Human cytolytic and IFN-γ-secreting CD8+ T lymphocytes specific for M. tuberculosis. Proc Natl Acad Sci USA 1998; 95:270.DOI: 10.1073/pnas.95.1.270
  • 11
    Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG & Grabstein KH. Characterization of human CD8+ T cells reactive with M. tuberculosis-infected antigen presenting cells. J Exp Med 1998; 187:1633.
  • 12
    Mohagheghpour N, Gammon D, Kawamura LM, Van Vollenhoven A, Benike CJ & Engleman EG. CTL response to M. tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998; 161:2400.
  • 13
    Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV & Boom WH. Activation of human CD8+αβ TCR+ cells by M. tuberculosis via an alternate class I MHC antigen processing pathway. J Immunol 1999; 162:372.
  • 14
    Smith SM, Malin AS, Lukey PT, Atkinson SE, Content J, Huygen K & Dockrell HM. Characterization of human M. bovis BCG-reactive CD8+ T cells. Infect Immun 1999; 67:5223.
  • 15
    Tsukaguchi K, Balaji KN & Boom WH. CD4+αβ T cell and γδ T cell responses to M. tuberculosis: similarities and differences in antigen recognition, cytotoxic effector function, and cytokine production. J Immunol 1995; 154:1786.
  • 16
    Rees A, Scoging A, Mehlert A, Young DB & Ivanyi J. Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol 1988; 18:1881.
  • 17
    Sundstrom C & Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17:565.
  • 18
    Peterlin BM, Gonwa TA & Stobo JD. Expression of HLA-DR by a human monocyte cell line is under transcriptional control. J Mol Cell Immunol 1984; 1:191.
  • 19
    Harris PE, Colovai AI, Maffei A, Liu Z & Suciu Foca N. MHC class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line. Immunology 1995; 86:606.
  • 20
    Schaible UE, Sturgill-Koszycki S, Schlesinger PH & Russell DG. Cytokine activation leads to acidification and increases maturation of M. avium-containing phagosomes in murine macrophages. J Immunol 1998; 160:1290.
  • 21
    Roberts PJ, Devalia V, Faint R, Pizzey A, Bainton AL, Thomas NSB, Pilkington GR & Linch DC. Differentiation-linked activation of the respiratory burst in monocytic cell line (U937) via FcRII. A study of activation pathways and their regulation. J Immunol 1991; 147:3104.
  • 22
    Bodmer JG, Pickbourne P & Richards S. Joint report on Ia serology. In: BodmerWR, ed. Histocompatibility Testing. Copenhagen: Munksgaard, 1977::35.
  • 23
    Moore MW, Carbone FR & Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54:777.
  • 24
    Ratcliffe LT, MacKenzie CR, Lukey PT & Ress SR. Reduced NK cell activity in multi-drug resistant pulmonary tuberculosis. Scand J Immunol (suppl.) 1992; 11:167.
  • 25
    Kasinrerk W, Baumruker T, Majdic O, Knapp W & Stockinger H. CD1 molecule expression on human monocytes induced by granulocyte–macrophage colony-stimulating factor. J Immunol 1993; 150:579.
  • 26
    Spencer JV & Braciale TJ. Incomplete CD8+ T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J Exp Med 2000; 191:1687.
  • 27
    Reis e Sousa C & Germain RN. MHC class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 1995; 182:841.
  • 28
    Minta JO & Pambrun L. In vitro induction of cytologic and functional differentiation of monocyte-like cell line U937 with phorbol myristate acetate. Am J Pathol 1985; 119:111.
  • 29
    Taimi M, Chateau MT, Cabane S & Marti J. Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D3 on differentiation of the human monocytic cell line U937. Leuk Res 1991; 15:1145.
  • 30
    Abu Kwaik Y. Induced expression of the Legionella pneumophila gene encoding a 20-kilodalton protein during intracellular infection. Infect Immun 1998; 66:203.
  • 31
    Arena A, Capozza AB, Delfino D & Iannello D. Production of TNF-α and interleukin-6 by differentiated U937 cells infected with Leishmania major. New Microbiol 1997; 20:233.
  • 32
    Chateau MT & Caravano R. Infection of differentiated U937 cells by Salmonella typhimurium: absence of correlation between oxidative burst and antimicrobial defense. FEMS Immunol Med Microbiol 1993; 7:111.
  • 33
    Kurts C, Miller JFAP, Subramaniam RM, Carbone FR & Heath WR. MHC class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998; 188:409.
  • 34
    Mazzaccaro RJ, Gedde M, Jensen ER, Van Santen HM, Ploegh HL, Rock KL & Bloom BR. MHC class I presentation of soluble antigen facilitated by M. tuberculosis infection. Proc Natl Acad Sci USA 1996; 93:11786.DOI: 10.1073/pnas.93.21.11786
  • 35
    Teitelbaum R, Cammer M, Maitland ML, Freitag NE, Condeelis J & Bloom BR. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci USA 1999; 96:15190.DOI: 10.1073/pnas.96.26.15190
  • 36
    Kovacsovics-Bankowski M, Clark K, Benacerraf B & Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 1993; 90:4942.
  • 37
    Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ & Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993; 361:359.
  • 38
    Morita CT, Beckman EM & Bukowski JF. et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995; 3:495.